Efficacy of trastuzumab in HER-2-positive advanced extramammary Paget's disease

被引：6

作者：

Zhu, Harrison ^{[1
]}

Lewis, Daniel J. ^{[2
]}

机构：

[1] Baylor Coll Med, Sch Med, Houston, TX 77030 USA

[2] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA

来源：

EXPERT OPINION ON BIOLOGICAL THERAPY | 2022年 / 22卷 / 05期

关键词：

Extramammary paget's disease; HER-2; trastuzumab; human epidermal growth factor; PACLITAXEL; PROTEIN;

D O I：

10.1080/14712598.2022.2066472

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：673 / 674

页数：2

共 14 条

[1] Hormonal Environment and HER2 Status in Extra-Mammary Paget's Disease (eMPD): A Systematic Literature Review and Meta-Analysis with Clinical Considerations
Angelico, Giuseppe
Santoro, Angela
Inzani, Frediano
Straccia, Patrizia
Arciuolo, Damiano
Mule, Antonino
Valente, Michele
Spadola, Saveria
D'Alessandris, Nicoletta
Garganese, Giorgia
Cianfrini, Federica
Piermattei, Alessia
Scambia, Giovanni
Zannoni, Gian Franco
[J]. DIAGNOSTICS, 2020, 10 (12)
[2] Metastatic Extramammary Paget's Disease of Scrotum Responds Completely to Single Agent Trastuzumab in a Hemodialysis Patient: Case Report, Molecular Profiling and Brief Review of the Literature
Barth, Peter
Al-Saleem, Essel Dulaimi
Edwards, Kristin W.
Millis, Sherri Z.
Wong, Yu-Ning
Geynisman, Daniel M.
[J]. CASE REPORTS IN ONCOLOGICAL MEDICINE, 2015, 2015
[3] A Case of Metastatic Extramammary Paget's Disease Responding to Trastuzumab plus Paclitaxel Combination Therapy
Hanawa, Fumie
Inozume, Takashi
Harada, Kazutoshi
Kawamura, Tatsuyosi
Shibagaki, Naotaka
Shimada, Shinji
[J]. CASE REPORTS IN DERMATOLOGY, 2011, 3 (03): : 223 - 227
[4] Ichiyama T, 2017, MOL CLIN ONCOL, V7, P763, DOI 10.3892/mco.2017.1422
[5] Human epidermal growth factor receptor 2 amplification as a biomarker for treatment in patients with lymph node-metastatic penoscrotal extramammary Paget's disease
Lu, Xiaolin
Zhang, Peipei
Zhu, Yao
Ye, Dingwei
[J]. ONCOLOGY LETTERS, 2019, 17 (03) : 2677 - 2686
[6] Extramammary Paget's disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies
Maeda, Takuya
Kitamura, Shinya
Nishihara, Hiroshi
Yanagi, Teruki
[J]. ONCOGENE, 2020, 39 (36) : 5867 - 5875
[7] The expression of HER-2 in extramammary Paget's disease
Masuguchi, Shinichi
Jinnin, Masatoshi
Fukushima, Satoshi
Makino, Takamitsu
Sakai, Keisuke
Inoue, Yuji
Igata, Toshikatsu
Ihn, Hironobu
[J]. BIOSCIENCE TRENDS, 2011, 5 (04) : 151 - 155
[8] Extramammary Paget's Disease: A Review of the Literature Part II: Treatment and Prognosis
Morris, Caroline R.
Hurst, Eva A.
[J]. DERMATOLOGIC SURGERY, 2020, 46 (03) : 305 - 311
[9] Trastuzumab deruxtecan in HER2-positive metastatic breast cancer and beyond
Perez, Jose
Garrigos, Laia
Gion, Maria
Janne, Pasi A.
Shitara, Kohei
Siena, Salvatore
Cortes, Javier
[J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (07) : 811 - 824
[10] Metastatic extramammary Paget's disease treated with paclitaxel and trastuzumab combination chemotherapy
Takahagi, Shunsuke
Noda, Hideki
Kamegashira, Akiko
Madokoro, Naoki
Hori, Ikuko
Shindo, Hajime
Mihara, Shouji
Hide, Michihiro
[J]. JOURNAL OF DERMATOLOGY, 2009, 36 (08) : 457 - 461

← 1 2 →